Precipio (NASDAQ: PRPO - Get Free Report) and Zhongchao (NASDAQ: ZCMD - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based
In Q4-2025 the Company generated ~$400K in Operating Cash Flow, and Adjusted EBITDA of close to $1M In Q4-2025 the Company generated ~$400K in Operating Cash Flow, and Adjusted EBITDA of close to $1M
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) saw a large growth in short interest in January. As of January 30th, there was short interest totaling 4,048 shares, a growth of 22.5% from the January
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) shares crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $20.29 and traded as low as $19.52.
Precipio (NASDAQ: PRPO - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses b
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 4,991 shares, an increase
AMH Equity Ltd lifted its stake in shares of Precipio, Inc. (NASDAQ: PRPO) by 370.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC)
Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding
Precipio (NASDAQ: PRPO - Get Free Report) and Tivic Health Systems (NASDAQ: TIVC - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two compani
Health Catalyst (NASDAQ: HCAT - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compan
Precipio (NASDAQ: PRPO - Get Free Report) and Privia Health Group (NASDAQ: PRVA - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses
Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates clear, positive impacts on patient care Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates cl
NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its
PRPO reports strong third-quarter 2025 results with higher revenue, positive cash flow and improved margins in core divisions.
Precipio, Inc. ( PRPO ) Q3 2025 Earnings Call November 17, 2025 5:00 PM EST Company Participants Ilan Danieli - Founder, President, CEO & Director Presentation Operator Welcome to the Precipio Third Q
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE